Fabbri, MargheritaBarbosa, RaquelRascol, Olivier2023-02-152023-02-152023-042193-8253PURE: 52823812PURE UUID: 8e594a86-c41e-42b4-8b17-5a1717f871a5Scopus: 85147269993PubMed: 36729359http://hdl.handle.net/10362/149278In Table 2 of this article, the data in the column headed ‘‘Route of administration, available dose’’ in row ‘‘CVT-301’’ was incorrect as it stated ‘‘Nasal inhalation’’ and should instead have been ‘‘Oral inhalation, 84 mg (in two 2 sequential inhalations)’’. The original article has been corrected.156556engNeurologyClinical NeurologyCorrection toother10.1007/s40120-023-00441-4Off-time Treatment Options for Parkinson’s Disease (Neurology and Therapy, (2023), 10.1007/s40120-022-00435-8)https://www.scopus.com/pages/publications/85147269993